Man Group PLC Vanda Pharmaceuticals Inc. Transaction History

Man Group PLC

$36 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.47 - $4.61 $165,623 - $220,035	47,730 New	47,730 $196,000
Q3 2023 Nov 14, 2023	SELL	$4.28 - $6.57 $3,441 - $5,282	-804 Reduced 0.29%	272,317 $1.18 Million
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $1.19 Million - $1.4 Million	201,789 Added 282.89%	273,121 $1.8 Million
Q1 2023 May 15, 2023	SELL	$6.18 - $7.99 $522,537 - $675,578	-84,553 Reduced 54.24%	71,332 $484,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $210,819 - $336,329	30,687 Added 24.51%	155,885 $1.15 Million
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $247,696 - $308,570	26,239 Added 26.52%	125,198 $1.24 Million
Q2 2022 Aug 15, 2022	BUY	$9.31 - $11.84 $406,297 - $516,709	43,641 Added 78.89%	98,959 $1.08 Million
Q1 2022 May 16, 2022	BUY	$10.84 - $16.55 $599,647 - $915,512	55,318 New	55,318 $625,000
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $453,704 - $621,208	-28,880 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$13.42 - $20.28 $3.95 Million - $5.97 Million	-294,392 Reduced 91.07%	28,880 $434,000
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $209,078 - $295,534	-21,400 Reduced 6.21%	323,272 $4.25 Million
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $205,040 - $264,440	-22,000 Reduced 6.0%	344,672 $3.33 Million
Q2 2020 Aug 14, 2020	SELL	$9.66 - $12.02 $433,540 - $539,457	-44,880 Reduced 10.91%	366,672 $4.2 Million
Q1 2020 May 15, 2020	BUY	$7.5 - $16.8 $899,287 - $2.01 Million	119,905 Added 41.11%	411,552 $4.26 Million
Q4 2019 Feb 18, 2020	BUY	$12.38 - $17.47 $2 Million - $2.83 Million	161,927 Added 124.83%	291,647 $4.79 Million
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $1.59 Million - $2.05 Million	129,720 New	129,720 $1.72 Million
Q2 2019 Aug 14, 2019	SELL	$13.37 - $18.85 $196,819 - $277,490	-14,721 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$17.59 - $31.05 $1.22 Million - $2.16 Million	-69,499 Reduced 82.52%	14,721 $271,000
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $2.12 Million - $3.52 Million	-111,815 Reduced 57.04%	84,220 $2.2 Million
Q3 2018 Nov 14, 2018	SELL	$18.25 - $23.0 $1.98 Million - $2.5 Million	-108,537 Reduced 35.64%	196,035 $4.5 Million
Q2 2018 Aug 14, 2018	SELL	$13.95 - $19.15 $2.96 Million - $4.06 Million	-212,028 Reduced 41.04%	304,572 $5.8 Million
Q1 2018 May 15, 2018	BUY	$14.05 - $20.2 $7.26 Million - $10.4 Million	516,600 New	516,600 $8.71 Million

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

Black Rock Inc. New York, NY

8.14M
Shares

$41.1 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

4.01M
Shares

$20.3 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.63M
Shares

$18.3 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$11.9 Million
0.94% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.26M
Shares

$11.4 Million
0.0% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $286M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Account